Genetic Epidemiology of Osteoarthritis

Osteoarthritis is a complex, multifactorial disorder characterised by degeneration of articular cartilage, subchondral bone alterations and synovial inflammation. Genetic epidemiology combines large‐scale population studies with molecular genetics to quantify heritable risk, identify susceptibility loci and elucidate pathogenic mechanisms. Twin and family studies estimate heritability at around 50 per cent, while genome‐wide association studies (GWAS) have uncovered over 100 risk variants, most mapping to non‐coding regions that regulate gene expression. Integration of GWAS with functional genomics—such as chromatin conformation, epigenetic profiling and transcriptomics—has begun to resolve causal effector genes and pathways. Mendelian randomisation and meta‐analyses have distinguished protective from deleterious genetic mechanisms, informing precision medicine approaches. Cross‐population analyses reveal both shared and ancestry‐specific risk variants, underlining the global burden of osteoarthritis and the need for diverse cohorts. Polygenic risk scores and stratification by joint site, sex and age‐at‐onset promise to improve prediction and guide targeted interventions, while ongoing efforts aim to translate genetic findings into novel therapies and biomarkers for early detection and disease modification.

Research from Nature Portfolio

Recent functional genomics approaches have systematically evaluated osteoarthritis-associated variants for regulatory activity. A massively parallel reporter assay tested over 1,600 single nucleotide variants, revealing six with allele-specific enhancer function and implicating an alternative transcript of HBP1 in Wnt signalling and cartilage homeostasis. In parallel, an integrated epigenomics, transcriptomics and proteomics analysis of paired intact and degraded human chondrocytes identified 49 genes consistently dysregulated across DNA methylation, RNA expression and protein abundance. Key findings included upregulation of extracellular matrix degradation enzymes, collagen catabolism factors and angiogenic mediators, providing a cohesive picture of molecular drivers of cartilage breakdown.

Genetic Epidemiology of Osteoarthritis publication trend

The graph below shows the total number of articles in genetic epidemiology of osteoarthritis across all publications each year (not limited to Nature Index journals).

Technical terms

Genome-wide association study (GWAS): A hypothesis-free scan of common genetic variants across the genome to identify loci associated with a trait or disease.

Chromatin conformation: The three-dimensional organisation of DNA in the nucleus, influencing long-range regulatory interactions between enhancers and promoters.

Enhancer-promoter interaction: Physical contact between regulatory DNA elements (enhancers) and gene transcription start sites (promoters) that modulates expression.

Mendelian randomisation: A method using genetic variants as instrumental variables to infer causal relationships between risk factors and disease outcomes.

Expression quantitative trait locus (eQTL): A genomic locus where variation correlates with gene expression levels, linking genotype to transcriptional regulation.

Polygenic risk score: A weighted sum of risk alleles across multiple loci, estimating an individual’s genetic predisposition to a complex trait.

References

1. Primary osteoarthritis chondrocyte map of chromatin conformation reveals novel candidate effector genes. Annals of the Rheumatic Diseases (2024).
2. The identification of distinct protective and susceptibility mechanisms for hip osteoarthritis: findings from a genome-wide association study meta-analysis of minimum joint space width and Mendelian randomisation cluster analyses. EBioMedicine (2023).
3. Leveraging osteoclast genetic regulatory data to identify genes with a role in osteoarthritis. Genetics (2023).
4. Integrative epigenomics, transcriptomics and proteomics of patient chondrocytes reveal genes and pathways involved in osteoarthritis. Scientific Reports (2017).
5. Functional testing of thousands of osteoarthritis-associated variants for regulatory activity. Nature Communications (2019).